InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Lydia Abad-Franch. Director active across 1 company, notably Swedish Orphan Biovitrum AB (publ). In total, 1 filings have been published. History available since 12 June 2026. The latest transaction was filed on 12 June 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
1 of 1 declaration